FIELD: chemical-pharmaceutical industry.
SUBSTANCE: group of inventions relates to use of a chromone derivative. Disclosed are: use of N-(3-{4-[4-(8-oxo-8H-[1,3]dioxolo[4,5-g]chromene-7-yl)-butyl]-piperazin-1-yl}-phenyl)methanesulphonamide or a pharmaceutically acceptable salt thereof as a medicament for treating a social interaction deficiency associated with an autism spectrum disorder, and a pharmaceutical composition of the same purpose based thereon.
EFFECT: technical result is a compound which represents a dopamine D3 receptor antagonist, eliminates the deficiency of social interactions caused by the prenatal action of sodium valproate.
4 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CHROMONE DERIVATIVES, METHOD FOR PREPARING THEM AND THERAPEUTIC USES THEREOF | 2010 |
|
RU2545214C2 |
| PARTIAL AGONIST OF DOPAMIN D2/D3 RECEPTORS - 4-{2-[4-(2,3-DICHLOROPHENIL)-PIPERAZIN-1-YL]-ETHYL}-PYPERIDIN-1-CARBONIC ACID METHILAMIDE, METHODS (OPTIONS) OF ITS OBTAINMENT AND APPLICATION | 2018 |
|
RU2677268C1 |
| SUBSTITUTED 4-(PHENYL-N-ALKYL)PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT | 2000 |
|
RU2262504C2 |
| 3-SUBSTITUTED 4-(PHENYL-N-ALKYL)-PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHODS FOR TREATMENT | 2000 |
|
RU2265013C2 |
| N-OXIDES AS PRODRUG OF PIPERAZINE AND PIPERIDINE DERIVATIVES | 2006 |
|
RU2394821C2 |
| NOVEL DOPAMINE NEUROTRANSMISSION MODULATORS | 2000 |
|
RU2386623C2 |
| APPLICATION OF ACTIVE PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | 2011 |
|
RU2563167C2 |
| METHODS FOR TREATMENT OF BEHAVIOR CHANGES | 2018 |
|
RU2799049C2 |
| DERIVATIVES OF HETEROARENE CARBOXAMIDE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2003 |
|
RU2320656C2 |
| 1, 2, 4-TRIAZINE-3, 5-DIONE DERIVATIVES FOR TREATING DISORDERS REACTING ON DOPAMINE D RECEPTOR MODULATION | 2008 |
|
RU2478633C2 |
